U.S. markets closed
  • S&P Futures

    3,433.75
    -18.00 (-0.52%)
     
  • Dow Futures

    28,044.00
    -145.00 (-0.51%)
     
  • Nasdaq Futures

    11,619.25
    -44.25 (-0.38%)
     
  • Russell 2000 Futures

    1,622.20
    -13.40 (-0.82%)
     
  • Crude Oil

    39.19
    -0.66 (-1.66%)
     
  • Gold

    1,900.90
    -4.30 (-0.23%)
     
  • Silver

    24.43
    -0.24 (-0.99%)
     
  • EUR/USD

    1.1841
    -0.0027 (-0.22%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • Vix

    27.55
    -0.56 (-1.99%)
     
  • GBP/USD

    1.3028
    -0.0010 (-0.07%)
     
  • USD/JPY

    104.8430
    +0.1530 (+0.15%)
     
  • BTC-USD

    13,125.52
    +104.62 (+0.80%)
     
  • CMC Crypto 200

    264.07
    +2.62 (+1.00%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,514.41
    -2.18 (-0.01%)
     

SHAREHOLDER ALERT: FENC NNOX FLDM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

·3 mins read

NEW YORK, NY / ACCESSWIRE / October 9, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Fennec Pharmaceuticals Inc. (NASDAQ:FENC)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/fennec-pharmaceuticals-inc-loss-submission-form?prid=9976&wire=1
Lead Plaintiff Deadline: November 2, 2020
Class Period: February 11, 2020 - August 10, 2020

Allegations against FENC include that: (1) the manufacturing facilities for PEDMARK, the Company's sole product candidate, did not comply with current good manufacturing practices; (2) as a result, regulatory approval for PEDMARK was reasonably likely to be delayed; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Nano-X Imaging Ltd. (NASDAQ:NNOX)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/nano-x-imaging-ltd-loss-submission-form?prid=9976&wire=1
Lead Plaintiff Deadline: November 16, 2020
Class Period: August 21, 2020 - September 15, 2020

Allegations against NNOX include that: (1) Nano-X's commercial agreements and its customers were fabricated; (2) Nano-X's statements regarding its "novel" Nanox System were misleading as the Company never provided data comparing its images with images from competitors' machines; (3) Nano-X's submission to the U.S. Food and Drug Administration admitted the Nanox System was not original; and (4) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Fluidigm Corporation (NASDAQ:FLDM)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/fluidigm-corporation-loss-submission-form?prid=9976&wire=1
Lead Plaintiff Deadline: November 20, 2020
Class Period: February 7, 2019 - November 5, 2019

Allegations against FLDM include that: (1) Fluidigm was experiencing longer sales cycles; (2) as a result, Fluidigm's revenue was reasonably likely to decline; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/609920/SHAREHOLDER-ALERT-FENC-NNOX-FLDM-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines